Blood transfusions and human recombinant erythropoietin in premature newborn infants

Archives of Disease in Childhood

Volumn 75, Issue 1 SUPPL., 1996, Pages

  Williamson, Paula ^a   Griffiths, Gill ^a   Norfolk, Derek ^a   Levene, Malcolm ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HAZARD; INTRAVENOUS DRUG ADMINISTRATION; PREMATURITY; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029948599     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/fn.75.1.f65     Document Type: Short Survey

References (28)

1. Brown MS, Berman ER, Luckey D. Prediction of the need for transfusion during anaemia of prematurity. J Pediatr 1990;116:773-8.
2. Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E, Yale C, et al. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child 1995;72:F29-F33.
3. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98:281-3.
4. Stanier P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS. Persistence of cytomegalovirus in peripheral blood from blood donors. BMJ 1989;299:897-8.
5. Norfolk DR, Williamson LM. Leucodepletion of blood products by filtration. Blood Reviews 1995;9:7-14.
6. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, et at. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331:625-8.
7. Andersen KG, Weinstein JH. Transfusion-associated graftversus-host disease. N Engl J Med 1990;323:315-21.
8. Perkins HA. Transfusion-induced immunologic unresponsiveness. Transfus Med Rev 1988;2:196-203.
9. Blumberg N, Heal JM. Immunology of blood transfusion. Curr Opin Hematol 1993; 330-6.
10. Novak RW, Abbott AK, Klein RL. T-cryptantigen determination affects mortality in necrotizing enterocolitis. Surg Gynaecol Obstet 1993;176:368-70.
11. Saugstad O-D. Neonatal oxygen radical disease. In: David TJ, ed. Recent Advances in Paediatrics, 10. Edinburgh: Churchill Livingstone, 1992:
12. Sullivan JL. Iron, plasma antioxidants and the "oxygen radical disease of prematurity". Am J Dis Child 1988; 142:1341-4.
13. Shannon KM, Mentzer WC, Abels RI. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
14. Nex E, Christensen NC, Olesen J. Volume of blood removed for analytical purposes during hospitalization of low-birthweight infants. Clin Chem 1981;27:759-61.
15. Bifano EM, Miggiani WP, Parker PR. Impact of transfusion practices in premature infants. Pediatr Res 1994;35:216A.
16. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC. Double-blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child 1993;68:291-6.
17. Meyer MP, Meyer JH, Commerford A, Han FM, Sive AA, Moller G, et al. Recombinant human erythropoietin in the treatment of the anaemia of prematurity: results of a double-blind, placebo-controlled study. Pediatr 1994; 93:918-23.
18. Ohls RK, Christensen RD. Erythropoietin administration to preterm infants during their first two weeks of life: a randomised, placebo-controlled trial. Pediatr Res 1993; 33:285A.
19. Ohls RK, Hunter DD, Christensen RD. A randomised, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anaemia of bronchopulmonary dysplasia. J Pediatr 1993;123:996-1000.
20. Shannon KM, Mentzer MC, Abels RI, Freeman P, Newton N, Thompson D, et al. Recombinant human erythropoietin in the anaemia of prematurity: results of a placebo controlled pilot study. J Pediatr 1991;118:949-55.
21. Shannon KM, Mentzer MC, Abels Rl, Wertz M, Thayer-Moriyama J, Li WY, et al. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992;120:586-92.
22. Bechensteen AG, Haga P, Halvorsen S, Whitelaw A, Liestol K, Lindemann R, et al. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Arch Dis Child 1993;60:19-23.
23. Ishikawa A, International Registry of Perinatal Trials. Record 6925.
24. Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birthweight infants. N Engl J Med 1994;330: 1173-8.
25. Obladen M, Scigalla P, Maier RF. Efficacy and safety of recombinat human erythropoietin to prevent anaemias of prematurity. Contrib Nephrol 1991; 88:314-26.
26. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anaemia of prematurity? Results of a randomised controlled study. Pediatr Res 1993; 34: 675-9.
27. Berger J. International Registry of Perinatal Trials. Record 5866.
28. Liu Ea, Mannino FL, Lane TA. Prospective, randomized trial of the safety and efficacy of a limited dsonor exposure transfusion program for premature neonates. J Pediatr 1994; 125: 92-6.